Amble

Compounded tirzepatide is no longer legally available for mass compounding (e.g., for weight loss without a specific medical need) because the FDA resolved the drug shortage in late 2024, but it remains available in very narrow, legitimate exceptions for individual patients with documented clinical justifications. Key Facts on Legality and Availability (2026) Condition Status Mass/Bulk Compounding Illegal since March 19, 2025; the shortage ended in December 2024 [1][3][9] 503A Patient-Specific Compounding Allowed only if a patient has a documented clinical reason (e.g., allergy to an inactive ingredient like polysorbate 80, or need for a non-standard dose/combination) [3][4][6] 503B Outsourcing Facilities Lost authority to compound tirzepatide on March 19, 2025 [3] FDA-Approved Alternatives Mounjaro and Zepbound are commercially available and recommended by the FDA as the primary source [1][3] How to Verify a "Legitimate" Source If you are considering compounded tirzepatide, a provider is only legitimate if they meet these strict criteria: Pharmacy Type: Must be a state-licensed 503A pharmacy (not a 503B outsourcing facility) [2][4]. Clinical Justification: The prescriber must document a specific medical need that the brand product cannot meet (e.g., verified allergy to an inactive ingredient) [3][7]. Cost or convenience alone is not a valid justification [7]. Prescription: Requires a valid, patient-specific prescription from a licensed healthcare provider [2][5]. Transparency: The pharmacy should provide a Certificate of Analysis (CoA) for the product [3]. Current Market Reality While the FDA has banned mass compounding, some telehealth platforms (e.g., Amble, Willow, Trim RX) continue to offer variations like tirzepatide/B12 combinations or altered excipients, arguing these fall outside the "essentially a copy" definition [8][13]. However, the FDA has proposed keeping tirzepatide off the 503B bulks list permanently, and access remains uncertain and legally contested [4][8]. Recommendation: For most patients, the only fully legitimate and safe route is to obtain FDA-approved Mounjaro or Zepbound, which are now widely available at standard pharmacies (including Walmart and LillyDirect) [1][3]. If you have a specific allergy or medical need, consult your doctor to see if a 503A pharmacy can legally compound a personalized formulation for you.

Mentioned in position 3 of 6

No, legitimate compounded tirzepatide is no longer available through regular pharmacies or standard medical providers as of July 2026, because the FDA officially ended widespread compounding sales after the tirzepatide shortage was declared resolved in late 2024, with all grace periods and deadlines for pharmacies to stop production passing by March 19, 2025 [1][2][6]. Key Details: Regulatory Status: The FDA determined that Eli Lilly’s manufacturing expansion resolved the shortage, legally prohibiting pharmacies from regularly compounding tirzepatide unless there is a specific medical need (e.g., an allergy to an inactive ingredient in brand-name versions) [1][2]. Legal Risk: While some online platforms (e.g., Amble, EllieMD, Willow, Mochi Health) still promote "variations" of tirzepatide, the FDA has warned that these are likely illegal "copycats" or replicas of commercially available drugs, exposing providers to legal risks [5]. Safety Concerns: Compounded tirzepatide is not FDA-approved, unregulated, and may be counterfeit or unsafe, with serious health risks [2][9]. Legitimate Alternatives: The only legitimate way to access tirzepatide is through FDA-approved brand-name medications: Mounjaro (for type 2 diabetes) and Zepbound (for weight loss), obtainable via a prescription from a healthcare provider [1][3]. Recommendation: Avoid purchasing tirzepatide from unverified sources claiming no prescription is needed or offering "research-grade" versions, as these are illegal and unsafe [2]. Instead, consult your doctor about Mounjaro or Zepbound, or explore other FDA-approved GLP-1 options like Wegovy (semaglutide) if cost or access is a barrier [3]. Brands to Consider: Mounjaro (Eli Lilly) – for diabetes Zepbound (Eli Lilly) – for weight loss Wegovy (Novo Nordisk) – alternative GLP-1 for weight loss These are the only safe, legal, and effective options available today.

Mentioned in position 1 of 6

No, legitimate compounded tirzepatide is generally no longer available for widespread use because the FDA has determined the tirzepatide shortage is resolved, ending the legal basis for pharmacies to widely compound it. The FDA set deadlines for pharmacies to phase out compounded tirzepatide injections, and those grace periods have since ended [1]. Pharmacies are now only allowed to compound tirzepatide in limited circumstances involving a specific medical need, not as a regular practice [1]. Any provider selling tirzepatide without a prescription or claiming it is "research-grade" is not legitimate and poses serious health risks due to potential counterfeit or unauthorized products [1][3]. While some online platforms (e.g., Amble, Mochi Health, Lavender Sky Health, Peak Wellness) still list compounded options [3][5][6], these may be operating in legal uncertainty or offering formulations that fall outside strict FDA definitions of "essential replicas," potentially exposing them to legal risks [3]. Recommendation: If you need tirzepatide, the only legitimate and FDA-approved options are Mounjaro or Zepbound, which you can obtain through a licensed healthcare provider who will send a prescription to a pharmacy [1]. Avoid purchasing from sources that do not require a prescription.

Mentioned in position 1 of 6

Compounded semaglutide typically costs between $129 and $500 per month without insurance, whereas brand-name Wegovy® costs approximately $1,300 to $1,865 per month out of pocket, making compounded semaglutide significantly cheaper for self-pay patients. Cost Breakdown Comparison Medication Type Typical Self-Pay Range (Without Insurance) Typical List Price (Retail) Compounded Semaglutide $129 – $500 per month [1][2][3] Not applicable (Custom dose) [1] Wegovy® (Brand Name) $1,300 – $1,865 per month [2][3][4] $1,349.02 per month [1][4] Key Details & Considerations Significant Savings: For patients without insurance, compounded semaglutide can cost up to 70% less than Wegovy®. For example, online providers like Mochi Health or Amble advertise rates as low as $99–$199 per month, compared to Wegovy's $1,349+ list price [5][6]. Insurance Impact: If you have commercial insurance and a Wegovy® savings card, your cost could drop to as little as $25 per month, which is cheaper than most compounded options [1]. However, insurance often does not cover compounded medications, so you would pay the full self-pay rate for compounded semaglutide regardless [2]. FDA Approval Warning: Compounded semaglutide is not FDA-approved and has not been reviewed for safety, effectiveness, or quality by the FDA, whereas Wegovy® is an FDA-approved medication [2][3]. Additional Fees: Some compounded providers may bundle additional costs such as membership fees, prescriber visit fees, or lab test costs, so the $129–$500 range may not reflect the total monthly expense for all patients [2]. Recommendation: If you are paying out of pocket and do not have insurance coverage for Wegovy®, compounded semaglutide (via providers like Mochi, Amble, or Master Rx) is the most affordable option. However, if you have commercial insurance and can access a Wegovy® savings card, the cost of Wegovy® may be lower than compounded semaglutide. Always verify total costs, including membership fees, before choosing a provider.

Mentioned in position 2 of 3